Quantitative assessment of homograft function 1 year after insertion into the pulmonary position: Impact of in situ homograft geometry on valve competence

European Heart Journal

Volumn 30, Issue 17, 2009, Pages 2147-2154

  Nordmeyer, Johannes ^a   Tsang, Victor ^a,b   Gaudin, Régis ^c   Lurz, Philipp ^a   Frigiola, Alessandra ^a,d   Jones, Alexander ^a   Schievano, Silvia ^a   Van Doorn, Carin ^a,b   Bonhoeffer, Philipp ^a   Taylor, Andrew M ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c L INSTITUT DU THORAX   (France)

^d IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

Conduit function; Congenital heart disease; Magnetic resonance imaging; Surgical pulmonary valve replacement

Indexed keywords

ADULT; ALLOGRAFT; ARTICLE; CARDIOPULMONARY BYPASS; CONGENITAL HEART DISEASE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART RIGHT VENTRICLE OUTFLOW TRACT; HUMAN; LUNG FLOW VOLUME CURVE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PULMONARY VALVE INSUFFICIENCY; PULMONARY VALVE REPLACEMENT; QUANTITATIVE ANALYSIS;

ADULT; ECHOCARDIOGRAPHY; FEMALE; GRAFT SURVIVAL; HEART DEFECTS, CONGENITAL; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PROSPECTIVE STUDIES; PULMONARY VALVE; PULMONARY VALVE INSUFFICIENCY; STROKE VOLUME; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 69949132613     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp204     Document Type: Article

References (14)

1. Bertranou EG, Blackstone EH, Hazelrig JB, Turner ME, Kirklin JW. Life expectancy without surgery in tetralogy of Fallot. Am J Cardiol 1978:423:458-466.
2. Hickey EJ, Veldtman G, Bradley TJ, Gengsakul A, Manlhiot C, Williams WG, Webb GD, McCrindle BW. Late risk of outcomes for adults with repaired tetralogy of Fallot from an inception cohort spanning four decades. Eur J Cardiothorac Surg 2009:35:156-164.
3. Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C Rosenthal M, Nakazawa M, Moller JH, Gillette PC Webb GD, Redington AN. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 2000;356:975-981.
4. Ross DN, Somerville J. Correction of pulmonary atresia with a homograft aortic valve. Lancet 1966:2:1446-1447.
5. Stark J, Bull C, Stajevic M, Jothi M, Elliott M, de LM. Fate of subpulmonary homograft conduits: determinants of late homograft failure. J Thorac Cardiovasc Surg 1998:115:506-514.
6. 6. Brown JW, Ruzmetov M, Rodefeld MD, Vijay P, Turrentine MW. Right ventricular outflow tract reconstruction with an allograft conduit in non-ross patients: risk factors for allograft dysfunction and failure. Ann Thorac Surg 2005;80:655-663.
7. 7. Bonhoeffer P, Boudjemline Y, Saliba Z, Merckx J, Aggoun Y, Bonnet D, Acar P, Le BJ, Sidi D, Kachaner J. Percutaneous replacement of pulmonary valve in a rightventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000:356:1403-1405.
8. 8. Schievano S, Coats L, Migliavacca F, Norman W, Frigiola A, Deanfield J, Bonhoeffer P, Taylor AM. Variations in right ventricular outflow tract morphology following repair of congenital heart disease: implications for percutaneous pulmonary valve implantation. J Cardiovasc Magn Reson 2007:9:687-695. (Pubitemid 46956908)
9. Hickey EJ, McCrindle BW, Blackstone EH, Yeh T Jr. Pigula F, Clarke D, Tchervenkov CI, Hawkins J. Jugular venous valved conduit (Contegra) matches allograft performance in infant truncus arteriosus repair. Eur J Cardiothorac Surg 2008:33:890-898.
10. 10. Tweddell JS, Pelech AN, Frommelt PC, Mussatto KA. Wyman JD, Fedderly RT, Berger S, Frommelt MA, Lewis DA, Friedberg DZ, Thomas JP Jr, Sachdeva R, Litwin SB. Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease. Circulation 2000:102(19 Suppl3):III130-III135. (Pubitemid 30819389)
11. Nordmeyer J, Tsang V, Gaudin R, Lurz P, Frigiola A, Jones A, Schievano S, van Doom C Bonhoeffer P, Taylor AM. Quantitative assessment of homograft function 1 year after insertion into the pulmonary position: impact of in situ homograft geomety on valve competence. Eur Heart J 2009:30:2147-2154. First published on 4 June 2009. doi:10.1093/eurheartj/ehp204.
12. Wald RM, Redington AN, Pereira K Provost YL, Paul NS. Oechslin EN, Silversides CK. Refining the assessment of pulmonary regurgitation in adults after tetralogy of Fallot repair: should we be measuring regurgitant fraction or regurgitant volume? Eur Heart J 2009;30:356-361.
13. 13. Oosterhof T, Meijboom FJ, Vliegen HW, Hazekamp MG. Zwinderman AH, Bouma BJ, van Dijk AP, Mulder BJ. Long-term follow-up of homograft function after pulmonary valve replacement in patients with tetralogy of Fallot Eur Heart J 2006:27:1478-1484. (Pubitemid 43998083)
14. Schaefermeier PK, Cabeza N, Besser JC Lohse P, Daebritz SH, Schmitz C, Reichart B. Sodian R. Potential cell sources for tissue engineering of heart valves in comparison with human pulmonary valve cells. ASAIO J 2009;55:86-92.